About the Company
BriaCell Therapeutics is a clinical-stage immuno-oncology company developing novel cell-based immunotherapies for solid tumors, including metastatic breast cancer. Our mission is to advance innovative immunotherapy approaches that improve outcomes for patients with difficult-to-treat malignancies.
Bria-IMTTM, BriaCell's lead candidate, was awarded Fast Track status by FDA and is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC). MBC is breast cancer that has spread to other tissues. Bria-IMTTM is a targeted cell-based immunotherapy.
Bria-OTSTM, a platform of personalized off-the-shelf cell-based immunotherapies, is being evaluated in a Phase 1/2 clinical study initially targeting breast cancer, with extension to prostate cancer, and other cancers.
Learn more at: BriaCell Advancing Cancer Immunotherapy Treatment
About the Position
BriaCell is seeking a highly motivated Scientist / Senior Scientist with expertise in genetic engineering and cell therapy development to join our cross-functional Discovery and CMC teams. This hybrid role will support both early-stage discovery research and CMC activities for BriaCell's genetically engineered cancer vaccine programs, including cell engineering, assay development, process optimization, analytical characterization, and manufacturing support.
The ideal candidate will have experience in viral vector-based cell engineering, immuno-oncology, and translational development of cell-based therapies, with the ability to work across research, process development, and manufacturing functions in a fast-paced biotech environment.
Responsibilities
Qualifications
To apply, please visit and click on "About Us" and submit your application through the Careers section.
Equal Employment Opportunity Statement
BriaCell is an Equal Opportunity Employer. We are committed to providing equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, sex, pregnancy, sexual orientation, gender identity or expression, national origin, age, disability, genetic information, veteran status, marital status, or any other characteristic protected by applicable federal, state, or local law.
Third-Party Agency Statement
BriaCell does not accept unsolicited resumes or candidate submissions from search firms, staffing agencies, or other third-party recruiters without a signed agreement in place. Any unsolicited resumes submitted to BriaCell, its employees, or hiring managers will be considered the property of BriaCell, and no fees will be paid in the event the candidate is hired.
Company Description BriaCell Therapeutics is a clinical-stage immuno-oncology company developing novel cell-based immunotherapies for solid tumors, including metastatic breast cancer. Our mission is to advance innovative immunotherapy approaches that improve outcomes for patients with difficult-to-treat malignancies. Company Description BriaCell Therapeutics is a clinical-stage immuno-oncology company developing novel cell-based immunotherapies for solid tumors, including metastatic breast cancer. Our mission is to advance innovative immunotherapy approaches that improve outcomes for patients with difficult-to-treat malignancies.